Starpharma Holdings Ltd SPHRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.07–0.07
- 52-Week Range
- $0.07–0.21
- Bid/Ask
- $0.05 / $0.08
- Market Cap
- $27.27 Mil
- Volume/Avg
- 100 / 25,745
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 32
- Website
- https://www.starpharma.com
Comparables
Valuation
|
Metric
|
SPHRF
|
SCLX
|
TLX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 152.11 |
Price/Book Value | 1.16 | — | 42.00 |
Price/Sales | 4.52 | 4.30 | 12.42 |
Price/Cash Flow | — | — | 258.19 |
Price/Earnings
SPHRF
SCLX
TLX
Financial Strength
|
Metric
|
SPHRF
|
SCLX
|
TLX
|
|---|---|---|---|
Quick Ratio | 5.22 | 0.12 | 1.19 |
Current Ratio | 5.60 | 0.15 | 1.43 |
Interest Coverage | — | −66.47 | 1.15 |
Quick Ratio
SPHRF
SCLX
TLX
Profitability
|
Metric
|
SPHRF
|
SCLX
|
TLX
|
|---|---|---|---|
Return on Assets (Normalized) | — | −107.39% | 3.71% |
Return on Equity (Normalized) | — | — | 11.73% |
Return on Invested Capital (Normalized) | — | — | 18.08% |
Return on Assets
SPHRF
SCLX
TLX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Vfzrwbfrc | Jxk | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Yhchdppyy | Szlsnwf | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Kxsljgsb | Zsskwl | $118.7 Bil | |||
| Moderna Inc
MRNA
| Bdwvxqmf | Jmvhw | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Pchyvgn | Hfztlnb | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Wqtkvpxc | Fwjzg | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Nzlqrmmx | Khkms | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Wxzksnntj | Rgnpgpf | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Lbgscdgc | Stsw | $15.0 Bil | |||
| Incyte Corp
INCY
| Szptfjtb | Bfzsyvx | $13.5 Bil |